Leviton A - Search Results

1

Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy.

Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF. Van Marter LJ, et al. Among authors: leviton a. Pediatrics. 1996 May;97(5):658-63. Pediatrics. 1996. PMID: 8628603

2

Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants.

Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. Van Marter LJ, et al. Among authors: leviton a. J Pediatr. 1990 Jun;116(6):942-9. doi: 10.1016/s0022-3476(05)80658-4. J Pediatr. 1990. PMID: 2189976 Clinical Trial.

3

Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia.

Van Marter LJ, Leviton A, Kuban KC, Pagano M, Allred EN. Van Marter LJ, et al. Among authors: leviton a. Pediatrics. 1990 Sep;86(3):331-6. Pediatrics. 1990. PMID: 2201940 Clinical Trial.

4

Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies.

Epstein MF, Leviton A, Kuban KC, Pagano M, Meltzer C, Skouteli HN, Brown ER, Sullivan KF. Epstein MF, et al. Among authors: leviton a. Pediatrics. 1988 Sep;82(3):350-4. Pediatrics. 1988. PMID: 3405664 Clinical Trial.

5

Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns.

Leviton A, Kuban KC, Pagano M, Allred EN, Van Marter L. Leviton A, et al. Pediatrics. 1993 Jun;91(6):1083-8. Pediatrics. 1993. PMID: 8502506 Clinical Trial.

6

Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.

Leviton A, Paneth N, Susser M, Reuss ML, Allred EN, Kuban K, Sanocka U, Hegyi T, Hiatt M, Shahrivar F, Van Marter LJ. Leviton A, et al. Pediatrics. 1997 Apr;99(4):E2. doi: 10.1542/peds.99.4.e2. Pediatrics. 1997. PMID: 9099777

7

Hypothyroxinemia of prematurity and the risk of cerebral white matter damage.

Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M. Leviton A, et al. J Pediatr. 1999 Jun;134(6):706-11. doi: 10.1016/s0022-3476(99)70285-4. J Pediatr. 1999. PMID: 10356138 Free article. Clinical Trial.

8

Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.

Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Van Marter LJ, et al. Among authors: leviton a. Pediatrics. 2000 Jun;105(6):1194-201. doi: 10.1542/peds.105.6.1194. Pediatrics. 2000. PMID: 10835057

9

Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.

Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M; Neonatology Committee for the Developmental Epidemiology Network. Van Marter LJ, et al. Among authors: leviton a. J Pediatr. 2001 Feb;138(2):198-204. doi: 10.1067/mpd.2001.110980. J Pediatr. 2001. PMID: 11233077

10

Congenital microcephaly: phenotypic features in a consecutive sample of newborn infants.

Vargas JE, Allred EN, Leviton A, Holmes LB. Vargas JE, et al. Among authors: leviton a. J Pediatr. 2001 Aug;139(2):210-4. doi: 10.1067/mpd.2001.115314. J Pediatr. 2001. PMID: 11487745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters